Cargando…
Tranexamic acid for patients with traumatic brain injury: a randomized, double-blinded, placebo-controlled trial
BACKGROUND: Traumatic brain injury (TBI) is commonly accompanied by intracranial bleeding which can worsen after hospital admission. Tranexamic acid (TXA) has been shown to reduce bleeding in elective surgery and there is evidence that short courses of TXA can reduce rebleeding in spontaneous intrac...
Autores principales: | Yutthakasemsunt, Surakrant, Kittiwatanagul, Warawut, Piyavechvirat, Parnumas, Thinkamrop, Bandit, Phuenpathom, Nakornchai, Lumbiganon, Pisake |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4221638/ https://www.ncbi.nlm.nih.gov/pubmed/24267513 http://dx.doi.org/10.1186/1471-227X-13-20 |
Ejemplares similares
-
Impact of Road Traffic Injury to Pediatric Traumatic Brain Injury in Southern Thailand
por: Tunthanathip, Thara, et al.
Publicado: (2017) -
Clinical Nomogram Predicting Intracranial Injury in Pediatric Traumatic Brain Injury
por: Tunthanathip, Thara, et al.
Publicado: (2020) -
The Optimal Operative Timing of Traumatic Intracranial Acute Subdural Hematoma Correlated with Outcome
por: Karnjanasavitree, Worawach, et al.
Publicado: (2018) -
CRASH-3 - tranexamic acid for the treatment of significant traumatic brain injury: study protocol for an international randomized, double-blind, placebo-controlled trial
por: Dewan, Yashbir, et al.
Publicado: (2012) -
Tranexamic acid for significant traumatic brain injury (The CRASH-3 trial): Statistical analysis plan for an international, randomised, double-blind, placebo-controlled trial
por: Roberts, Ian, et al.
Publicado: (2018)